chartexchange

Xeris Biopharma Raises Fiscal 2026 Revenue Guidance on Thursday

GuruFocus | Nov 9, 2026 6:30 AM EST

The company now expects fiscal 2026 revenue of $395 million to $405 million. Related Stocks: XERS ,

Read original article